Can-Fite BioPharma Ltd.

NYSE:CANF

Pharmaceutical Preparations·RAMAT GAN, L3

Governanceproxy statements · beneficial ownership

Ownership Filings

40 shown

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
2/14/24	SC 13G	SC 13G	→
2/14/22	SC 13G/A	SC 13G/A	→
2/11/22	SC 13G/A	AMENDMENT NO. 3 TO SCHEDULE 13G	→
2/4/22	SC 13G/A	CANF 13G/A	→
2/16/21	SC 13G/A	SC 13G/A	→
↓